Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay D Amsterdam

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
The Journal of Clinical Psychiatry|March 14, 2003
A double-blind, placebo-controlled trial of the safety and efficacy of selegiline transdermal system without dietary restrictions in patients with major depressive disorderJay D Amsterdam
Journal of Clinical Psychopharmacology|May 18, 2010
Efficacy and mood conversion rate of short-term fluoxetine monotherapy of bipolar II major depressive episodeJay D Amsterdam, Justine Shults
Journal of Affective Disorders|June 1, 2005
Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression--lack of manic inductionJay D Amsterdam, Justine Shults
Journal of Affective Disorders|August 13, 2008
Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode?Jay D Amsterdam, Justine Shults
Bipolar Disorders|September 25, 2023
Multi-trial, aggregated, individual participant data mega-analysis of short-term antidepressant versus mood stabilizer monotherapy of bipolar type II major depressive episodeJay D Amsterdam, Colin Xu
Journal of Affective Disorders|October 11, 2005
MAOI efficacy and safety in advanced stage treatment-resistant depression--a retrospective studyJay D Amsterdam, Justine Shults
The American Journal of Psychiatry|April 3, 2010
Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution studyJay D Amsterdam, Justine Shults
International Clinical Psychopharmacology|August 13, 2005
Fluoxetine monotherapy of bipolar type II and bipolar NOS major depression: a double-blind, placebo-substitution, continuation studyJay D Amsterdam, Justine Shults
Journal of Clinical Psychopharmacology|March 18, 2008
Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label studyJay D Amsterdam, Justine Shults
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 10, 2002
Venlafaxine versus stimulant therapy in patients with dual diagnosis ADD and depressionMady Hornig-Rohan, Jay D Amsterdam
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
The Journal of Clinical Psychiatry|March 14, 2003
A double-blind, placebo-controlled trial of the safety and efficacy of selegiline transdermal system without dietary restrictions in patients with major depressive disorderJay D Amsterdam
Journal of Clinical Psychopharmacology|May 18, 2010
Efficacy and mood conversion rate of short-term fluoxetine monotherapy of bipolar II major depressive episodeJay D Amsterdam, Justine Shults
Journal of Affective Disorders|June 1, 2005
Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression--lack of manic inductionJay D Amsterdam, Justine Shults
Journal of Affective Disorders|August 13, 2008
Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode?Jay D Amsterdam, Justine Shults
Bipolar Disorders|September 25, 2023
Multi-trial, aggregated, individual participant data mega-analysis of short-term antidepressant versus mood stabilizer monotherapy of bipolar type II major depressive episodeJay D Amsterdam, Colin Xu
Journal of Affective Disorders|October 11, 2005
MAOI efficacy and safety in advanced stage treatment-resistant depression--a retrospective studyJay D Amsterdam, Justine Shults
The American Journal of Psychiatry|April 3, 2010
Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution studyJay D Amsterdam, Justine Shults
International Clinical Psychopharmacology|August 13, 2005
Fluoxetine monotherapy of bipolar type II and bipolar NOS major depression: a double-blind, placebo-substitution, continuation studyJay D Amsterdam, Justine Shults
Journal of Clinical Psychopharmacology|March 18, 2008
Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label studyJay D Amsterdam, Justine Shults
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 10, 2002
Venlafaxine versus stimulant therapy in patients with dual diagnosis ADD and depressionMady Hornig-Rohan, Jay D Amsterdam
Pageof 10